Tools

Nephrology

Publications

2015 Print Publications

  1. Amro OW*, Perrone RD. How does a patient’s primary renal disease impact chronic dialysis management?: patients with autosomal dominant polycystic kidney disease. Semin Dial 2015;28:470-3. Epub 2015 May 27; PMID:26012364.
  2. Bansal N, Katz R, De Boer IH, Peralta CA, Fried LF, Siscovick DS, Rifkin DE, Hirsch C, Cummings SR, Harris TB, Kritchevsky SB, Sarnak MJ, Shlipak MG, Ix JH. Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD. Clin J Am Soc Nephrol 2015;6:363-71. Epub 2015 Feb 20; PMID:25710804.
  3. Cerdá J, Liu KD, Cruz DN, Jaber BL, Koyner JL, Heung M, Okusa MD, Faubel S; AKI Advisory Group of the American Society of Nephrology. Promoting kidney function recovery in patient with AKI requiring RRT. Clin J Am Soc Nephrol 2015;10:1859-67. Epub 2015 Jul 2; PMID:26138260.
  4. Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC; Conference Participants. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2015;88-17-27. Epub 2015 Mar 18; PMID:25786098.
  5. Charytan DM, Lewis EF, Desai AS, Weinrauch LA, Ivanovick P, Toto RD, Claggett B, Liu J, Hartley LH, Finn P, Singh AK, Levey AS, Pfeffer MA, McMurray JJ, Solomon SD. Cause of death in patients with diabetic CKD enrolled in the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT). Am J Kidney Dis 2015;66:429-40. Epub 2015 Apr 29; PMID:25935581.
  6. Dabar G, Harmouche C, Salameh P, Jaber BL, Jamaleddine G, Waked M, Yazbeck P. Community- and healthcare-associated infections in critically ill patients: a multicenter cohort study. Int J Infect Dis 2015; 37:80-85. Epub 2015 Jun 4; PMID:26051976.
  7. Dad T*, Weiner DE. Stroke and chronic kidney disease: epidemiology, pathogenesis, and management across kidney disease stages. Semin Nephrol 2015;35:311-22; PMID:26355250.
  8. Deo R, Katz R, de Boer IH, Sotoodehnia N, Kestenbaum B, Mukamal KJ, Chonchol M, Sarnak MJ, Siscovick D, Shlipak MG, Ix JH. Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study. Am J Kidney Dis 2015;66:40-6. Epub 2015 Jan 5; PMID:25572028.
  9. Drew DA*, Lok CE, Cohen JT, Wagner M, Tangri N, Weiner DE. Vascular access choice in incident hemodialysis patients: a decision analysis. J Am Soc Nephrol 2015;26:183-91. Epub 2014 Jul 25; PMID:250634436.
  10. Drew DA*, Weiner DE, Tighiouart H, Scott T, Lou K, Kantor A, Fan L, Strom JA, Singh AK, Sarnak MJ. Cognitive function and all-cause mortality in maintenance hemodialysis patients. Am J Kidney Dis 2015;65:303-11. Epub 2014 Sep 17; PMID:25240262.
  11. Eckfeldt JH, Karger AB, Miller WG, Rynders GP, Inker LA. Performance in measurement of serum cystatin C by laboratories participating in the College of American Pathologists 2014 CYS Survey. Arch Pathol Lab Med 2015;139:888-93. Epub 2015 Mar 30; PMID:25825481.
  12. Fan L, Levey AS, Gudnason V, Eiriksdottir G, Andresdottir MB, Gudmundsdottir H, Indridason OS, Palsson R, Mitchell G, Inker LA. Comparing GFR estimating equations using cystatin C and creatininine in elderly individuals. J Am Soc Nephrol 2015;26:1982-9. Epub 2014 Dec 19; PMID:25537647.
  13. Foster MC, Coresh J, Bonventre JV, Sabbisetti VS, Waikar SS, Mifflin TE, Nelson TE, Nelson RG, Grams M, Feldman HI, Vasan RS, Kimmel PL, Hsu CY, Liu KD; CKD Biomarkers Consortium. Urinary biomarkers and risk of ESRD in the atherosclerosis risk in communities study. Clin J Am Soc Nephrol 2015;10:1956-63. Epub 2015 Sep 8; PMID:26350438.
  14. Foster MC, Hwang SJ, Massaro JM, Jacques PF, Fox CS, Chu AY. Lifestyle factors and indices of kidney function in the Framingham Heart Study. Am J Nephrol 2015;41:267-74. Epub 2015 May 20; PMID:25998023.
  15. Foster MC, Inker LA, Hsu C, Eckfeldt JH, Levey AS, Pavkov ME, Myers BD, Bennett PH, Kimmel PL, Vasan RS, Coresh J, Nelson RG; CKD Biomarkers Consortium. Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes. Am J Kidney Dis 2015;66:75-83. Epub 2015 Mar 12; PMID:25773485.
  16. Foster MC, Varothai N*, Weiner DE. Estimation of life-years saved by solid-organ transplant. JAMA Surg 2015;150:1015; PMID:26244845.
  17. Garimella PS*, Biggs ML, Katz R, Ix JH, Bennett MR, Devarajan P, Kestenbaum BR, Siscovick DS, Jensen MK, Shlipak MG, Chaves PH, Sarnak MJ. Urinary uromodulin, kidney function, and cardiovascular disease in elderly adults. Kidney Int 2015;88:1126-34. Epub 2015 Jul 8; PMID:26154925.
  18. Garimella PS*, Ix JH, Katz R, Shlipak MG, Chiqui MH, Siscovick DS, Kramer H, Sibley CT, Sarnak MJ. Association of albumin-creatinine ratio and cystatin C with change in ankle-brachial index: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2015;65:33-40. Epub 2014 Jul 3; PMID:24998036.
  19. Golla MS, Acharjee S, Jaber BL, Garcia LA. Common iliac artery thrombosis following pelvic surgery resulting in kidney allograft failure successfully treated by percutaneous transluminal angioplasty with balloon-expandable covered stent. Case Rep Nephrol 2015;2015:291796; PMID:26355669.
  20. Grams ME, Sang Y, Ballew SH, Gansevoort RT, Kimm H, Kovesdy CP, Naimark D, Oien C, Smith DH, Coresh J, Sarnak MJ, Stengel B, Tonelli M; CKD Prognosis Consortium (ckdpc@jhmi.edu). A meta-analysis of the association of estimated GFR, albuminuria, age, race and sex with acute kidney injury. Am J Kidney Dis 2015;66:591-601. Epub 2015 May 2; PMID:25943717.
  21. Hogan MC, Abebe K, Torres VE, Chapman AB, Bae KT, Tao C, Sun H, Perrone RD, Steinman TI, Braun W, Winklhofer FT, Miskulin DC, Rahbari-Oskoui F, Brosnahan G, Masoumi A, Karpouv IO, Spillane S, Flessner M, Moore CG, Shrier RW. Liver involvement in early autosomal dominant polycystic kidney disease. Clin Gastroentol Hepatl 2015;13:155-64. Epub 2014 Aug 9; PMID:25111236.
  22. Hsu CY, Ballard S, Battle D, Bonventre JV, Böttinger EP, Feldman HI, Klein JB, Coresh J, Eckfeldt JH, Inker LA, Kimmel PL, Kusek JW, Liu KD, Mauer M, Mifflin TE, Molitch ME, Nelsesteuen GL, Rebholz CM, Rovin BH, Sabbisetti VS, Van Eyk JE, Vasan RS, Waikar SS, Whitehead KM, Nelson RG; CKD Biomarkers Consortium. Cross-disciplinary biomarkers research: lessons learned by the CKD Biomarkers Consortium. Clin J Am Soc Nephrol 2015;10:894-902. Epub 2015 Mar 4; PMID:25739849.
  23. Inker LA, Fan L, Levey AS. Assessment of renal function. In Johnson RJ, Feehally J, Floege J (eds). Comprehensive Clinical Nephrology 5th Edition. Elsevier Saunders Philadelphia, PA 2015; pp 30-38.
  24. Inker LA, Okparavero A, Tighiouart H, Aspelun T, Andresdottir MB, Eiriksdottir G, Harris T, Launer L, Nikulasdottir H, Sverrisdottir JE, Gudmundsdottir H, Noubary F, Mitchell G, Palsson R, Indridason OS, Gudnason V, Levey AS. Midlife blood pressure and late-life GFR and albuminuria: an elderly general population cohort. Am J Kidney Dis 1025;66:240-8. Epub 2015 May 16; PMID:25987258.
  25. Inker LA, Tighiouart H, Aspelund T, Gudnason V, Harris T, Indridason OS, Palsson R, Shastri S, Levey AS, Sarnak MJ. Lifetime risk of stage 3-5 CKD in a community-based sample in Iceland. Clin J Am Soc Nephrol 2015;10:1575-84. Epub 2015 Aug 18; PMID:26286924.
  26. Ix JH, Biggs ML, Mukamal K, Djousse L, Siscovick D, Tracy R, Katz R, Delaney JA, Chaves P, RifkinDE, Hughes-Austin JM, Garimella PS*, Sarnak MJ, Shlipak MG, Kizer JR. Urine collagen fragments and CKD progression – The Cardiovascular Study. J Am Soc Nephrol 2015;26:2494-503. Epub 2015 Feb 5; PMID:25655067.
  27. James MT, Grams ME, Woodward M, Elley CR, Green JA, Wheeler DC, de Jong P, Gansevoort RT, Levey AS, Warnock DG, Sarnak MJ; CKD Prognosis Consortium (ckdpc@jhmi.edu). A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury. Am J Kidney Dis 2015;66:602-12. Epub 2015 May 11; PMID:25975964.
  28. Johnson DS, Kapoian T, Meyer KB. Staff-Assisted In-Center Hemodialysis. In: Stephen Z. Fadem, ed. Essentials of Chronic Kidney Disease. Hauppage, NY: Nova Science Publishers, 2015.
  29. Joseph A, Pilichowska M, Boucher H, Kiernan M, DeNofrio D, Inker LA. BK virus nephropathy in heart transplant recipients. Am J Kidney Dis 2015;65:949-55. Epub 2015 Mar 12; PMID:25773482.
  30. Jotwani V, Scherzer R, Abraham A, Estrella MM, Bennett M, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Ix JH, Sarnak MJ, Parikh CR, Shlipak MG. Association of urine α1-microglobulin with kidney function decline and mortality in HIV-infected women. Clin J Am Soc Nephrol 2015;10:63-73. Epub 2014 Nov 4; PMID:25370597.
  31. Kapoian T, Meyer KB, Johnson DS. Infection prevention and the medical director: uncharted territory. Clin J Am Soc Nephrol 2015;10:863-74. Epub 2015 Feb 20; PMID:25710803.
  32. Kiernan MS, Gregory D, Sarnak MJ, Rossignol P, Massaro J, Kociol R, Zannad F, Konstam MA. Early and late effects of high- versus low-dose angiotensin receptor blockade on renal function and outcomes in patients with chronic heart failure. JACC Heart Fail 2015;3:214-24.
  33. Kim DH, Grodstein F, Newman AB, Chaves PH, Odden MC, Klein R, Sarnak MJ, Lipsitz LA. Microvascular and macrovascular abnormalities and cognitive and physical function in older adults: Cardiovascular Health Study. J Am Geriar Soc 2015;63:1886-93. Epub 2015 Sep 4; PMID:26338279.
  34. Knight T, Schaefer C, Krasa H, Oberdhan D, Chapman A, Perrone RD. Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data. Clinicoecon Outcomes Res 2015;7:123-32. eCollection 2015; PMID:25759590.
  35. Koulouridis I, Price LL, Madias NE, Jaber BL. Hospital-acquired acute kidney injury and hospital readmission: a cohort study. Am J Kidney Dis 2015;65:275-82. Epub 2014 Oct 22; PMID:25446018.
  36. Kraut JA, Madias NE. Lactic acidosis. N Engl J Med 2015;372:1078-9; PMID:25760366.
  37. Ladin K, Weiner DE. Better informing older patients with kidney failure in an era of patient-centered care. Am J Kidney Dis 2015;65:372-4; PMID:25704042.
  38. Lam NN, Lentine KL, Levey AS, Kasiske BL, Garg AX. Long-term medical risks to the living kidney donor. Nat Rev Nephrol 2015;11:411-9. Epub 2015 May 5; PMID:25941060.
  39. Laws RL, Brooks DR, Amador JJ, Weiner DE, Kaufman JS, Ramirez-Rubio O, Riefkohl A, Scammell MK, López-Pilarte D, Sanchez JM, Parikh CR, McClen MD. Changes in kidney function among Nicaraguan sugarcane workers. Int J Occup Environ Health 2015;21:241-50. Epub 2015 Jan 28; PMID:25631575.
  40. Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA 2015; 313:837-846 (includes Appendix published online); PMID:25710660.
  41. Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA 2015;313:837-46; PMID:25710680.
  42. Levey AS, Eckfeldt JH. Using glomerular filtration rate estimating equations: clinical and laboratory considerations. Clin Chem 2015;61:1226-9. Epub 2015 Aug 21; PMID:26296582.
  43. Levey AS, Inker LA, Coresh J. Chronic kidney disease in older people. JAMA 2015;314:557-8. Epub 2015 Aug 11; PMID:26023868.
  44. Lewis EF, Claggett B, Parfrey PS, Burdmann EA, McMurray JJ, Solomon SD, Levey AS, Ivanovick P, Eckardt KU, Kewalramani R, Toto R, Pfeffer MA. Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus. Am Heart J 2015;170:322-9. Epub 2015 May 22; PMID:26299230.
  45. Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, Jafar T, Jassal SK, Landman GW, Muntner P, Roderick P, Sairenchi T, Schöttker B, Shankar A, Shlipak M, Tonelli M, Townend J, van Züilen A, Yamagishi K, Yamashita K, Gansevoort R, Sarnak M, Warnock DG, Woodward M, Ärnlöv J; CKD Prognosis Consortium. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol 2015;3:514-25. Epub 2015 May 28; PMID:26028594.
  46. Matsushita K, Sang Y, Bellew SH, Shlipak M, Katz R, Rosas SE, Peralta CA, Woodward M, Kramer HJ, Jacobs DR, Sarnak MJ, Coresh J. Subclinical atherosclerosis measures for cardiovascular prediction in CKD. J Am Soc Nephrol 2015;26:439-47. Epub 2014 Aug 21; PMID:25145930.
  47. Mehta T, Bůžková P, Sarnak MJ, Chonchol M, Cauley JA, Wallace E, Fink HA, Robbins J, Jalal D. Serum urate levels and the risk of hip fractures: data from the Cardiovascular Health Study. Metabolism 2015;64:438-46. Epub 2014 Nov 21; PMID:25491429.
  48. Mehta T, Nuccio E, McFann K, Madero M, Sarnak MJ, Jalal D. Association of uric acid with vascular stiffness in the Framingham Heart Study. Am J Hypertens 2015;28:877-83.
  49. Meyer KB. Dialysate fluid endotoxin: assaying claims to cleanliness. Am J Kidney Dis 2015;65:817-9; PMID:26003609.
  50. Michener KH, Mitchell GF, Noubary F, Huang N, Harris T, Andresdottir MB, Palsson R, Gudnason V, Levey AS. Aortic stiffness and kidney disease in an elderly population. Am J Nephrol 2015;41:320-8. Epub 2015 Jun 6; PMID:26067356.
  51. Moore CG, Spillane S, Simon G, Maxwell B, Rahbari-Oskoui FF, Braun WE, Chapman AB, Schrier RW, Torres VE, Perrone RD, Steinman TI, Brosnahan G, Czarnecki PG, Harris PC, Miskulin DC, Flessner MF, Bae KT, Abebe KZ, Hogan MC. Closeout of the HALT-PKD trials. Contemp Clin Trials 2015;44:48-55; PMID:26231556.
  52. National Kidney Foundation (Members: Inrig J, Mehrotra R, Rocco MV, Suri RS, Weiner DE). KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis 2015;66:884-930; PMID:26498416.
  53. Perrone RD, Malek AM, Watnick T. Vascular complications in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 2015;11:589-98. Epub 2015 Aug 11; PMID:26260542.
  54. Perrone RD, Neville J, Chapman AB, Gitomer BY, Miskulin DC, Torres VE, Czerwiec FS, Dennis E, Kisler B, Kopko S, Krasa HB, LeRoy E, Castedo J, Schrier RW, Broadbent S. Therapeutic area data standards for autosomal dominant polycystic kidney disease: a report from the Polycystic Kidney Disease Outcomes Consortium (PKDOC). Am J Kidney Dis 2015;66:583-90. Epub 2015 Jun 15; PMID:26088508.
  55. Rebholz CM, Grams ME, Coresh J, Selvin E, Inker LA, Levey AS, Kimmel PL, Vasan RS, Eckfeldt JH, Feldman HI, Hsu CY, Lutsey PL; for the Chronic Kidney Disease Biomarkers Consortium. Serum fibroblast growth factor-23 is associated with incident kidney disease. J Am Soc Nephrol 2015;26:192-200. Epub 2014 Jul 24; PMID:25060052.
  56. Rebholz CM, Grams ME, Matsushita K, Inker LA, Foster MC, Levey AS, Selvin E, Coresh J. Change in multiple filtration markers and subsequent risk of cardiovascular disease and mortality. Clin J Am Soc Nephrol 2015;10:941-8. Epub 2015 Mar 30; PMID:25825481.
  57. Richardson MM, Grobert ME, Meyer KB. Measurement and analysis of patient-reported outcomes. In: Parfrey PS, Barrett BJ, eds. Clinical Epidemiology Practice and Methods, 2d edition. New York: Springer Humana Press, 2015.
  58. Richardson MM, Paine SS, Grobert ME, Stidley CA, Gabbay E, Harford AM, Zager PG, Miskulin DC, Meyer KB. Satisfaction with care of patients on hemodialysis. Clin J Am Soc Nephrol 2015;10:1428-34. Epub 2015 Jun 30; PMID:26130617.
  59. Rifkin DE, Kiernan M, Sarnak MJ. Hitting the mark: blood pressure targets and agents in those with prevalent cardiovascular disease and heart failure. Adv Chronic Kidney Dis 2015;22:140-4; PMID:25704351.
  60. Sarnak MJ, Bloom R, Muntner P, Rahman M, Saland JM, Wilson PW, Fried L. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD. Am J Kidney Dis 2015;65:354-66. Epub 2014 Nov 18; PMID:25465166.
  61. Shafi T, Levey AS, Inker LA, Schwartz GJ, Knight C, Abraham AG, Eckfaldt JH, Coresh J. Plasma iohexol clearance for assessing residual kidney function in dialysis patients. Am J Kidney Dis 2015;66:728-30. Epub 2015 Jul 21; PMID:26209541.
  62. SPRINT Research Group (Weiner DE), Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnsson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103-16. Epub 2015 Nov 9; PMID:26551272.
  63. Sud M, Tangri N, Pintilie M, Levey AS, Naimark DM. ESRD and death after heart failure in CKD. J Am Soc Nephrol 2015;26:715-22. Epub 2014 Sep 4; PMID:25190730.
  64. Tangri N, Miskulin DC, Zhou J, Bandeen-Roche K, Michels WM, Ephraim PL, Dermott A, Crews DC, Scilla JJ, Sozio SM, Shafi T, Jaar BG, Meyer KB, Ebony Boulware L; for the DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators. Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD Study. Neph Dial Transpl 2015;30:667-75. Epub 2014 Nov 2; PMID:25366328.
  65. Thamcharoen N, Susantitaphong P, Wongrakpanich S, Chongsathidkiet P, Tantrachoti P, Pitukweerakul S, Avihingsanon Y, Praditpornsilpa K, Jaber BL, Eiam-Ong S. Effect of N- and T-type calcium channel blocker on proteinuria, blood pressure and kidney function in hypertensive patients: a meta-analysis. Hypertens Tes 2015;38:847-55; PMID:26638729.
  66. Tsipotis E, Shuja A, Jaber BL. Albumin dialysis for liver failure: a systematic review. Adv Chronic Kidney Dis 2015;22:382-90; PMID:26311600.
  67. Van Buren PN, Lewis JB, Dwyer JP, Greene T, Middleton J, Sika M, Umanath K, Abraham JD, Arfeen SS, Bowline IG, Chernin G, Fadem SZ, Goral S, Koury M, Sinsakul MV, Weiner DE; Collaborative Study Group. The phosphate binder ferric citrate and mineral metabolism and inflammatory markers in maintenance dialysis patients: results from prespecified analyses of a randomized clinical trial. Am J Kidney Dis 2015;66:479-88. Epub 2015 May 7; PMID:25958079.
  68. Weiner DE, Brunelli SM. In reply to ‘More evidence needed before lower dialysis sodium concentrations can be recommended.’ Am J Kidney Dis 2015;65:520; PMID:25704047.
  69. Weiner DE, Kapoian T, Johnson DS. Nutrition, vitamin D, and health outcomes in hemodialysis: time for feeding frenzy? Curr Opin Nephrol Hypertens 2015;24:546-56; PMID:26418058.
  70. Woodard T, Sigurdsson S, Gotal JD, Torjesen AA, Inker LA, Aspelund T, Eiriksdottir G, Gudnason V, Harris TB, Launer LJ, Levey AS, Mitchell GF. Segmental kidney volumes measured by dynamic contrast-enhanced magnetic resonance imaging and their association with CKD in older people. Am J Kidney Dis 2015;65:41-8. Epub 2014 Jul 10; PMID:25022339.
  71. Woodard T, Sigurdsson S, Gotal JD, Torjessen AA, Inker LA, Aspelund R, Eiriksdottir G, Gudnason V, Harris TB, Launer LJ, Levey AS, Mitchell GF. Mediation analysis of aortic stiffness and renal microvascular function. J Am Soc Nephrol 2015;26:1181-7. Epub 2014 Oct 7; PMID:25294231.
  72. Wright S, Gilbert SJ. Tumor Lysis Syndrome in Onco-Nephrology: Cancer, Chemotherapy, and the Kidney. Edited by Jhaveri KD and Salahudeen AK. Springer 2015; New York: 163-182.

2015 Division Epublications

  1. Alseiari M, Meyer KB, Wong JB. Evidence underlying KDIGO (Kidney Disease: Improving Global Outcomes) guideline recommendations: a systematic review. Am J Kidney Dis 2015 Oct 29;pii:S0272-6386(15)01238-X; doi:10.1053/j.ajkd.09.016; PMID:26526035.
  2. Bansal N, Carpenter MA, Weiner DE, Levey AS, Pfeffer M, Kusek JW, Cai J, Hunsicker LG, Park M, Bennett M, Liu KD, Hsu CY. Urine injury biomarkers and risk of adverse outcomes in recipients of prevalent kidney transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial. J Am Soc Nephrol 2015 Nov 4;pii:ASN.2015030292; PMID:26538631.
  3. Cooper LL, Woodard T, Sigurdsson S, van Buchem MA, Torjesen AA, Inker LA, Aspelund T, Eiriksdottir G, Harris TB, Gudnason V, Launer LJ, Mitchell GF. Cerebrovascular damage mediates relations between aortic stiffness and memory. Hypertension 2015 Nov 16;pii:HYPERTENSIONAHA.115.06395; PMID:26573713.
  4. Delgado C, Grimes BA, Glidden DV, Shlipak M, Sarnak MJ, Johansen KL. Association of frailty based on self-reported physical function with directly measured kidney function and mortality. BMC Nephrol 2015 Dec 9; 16:203;doi:10.1186/s12882-015-0202-6; PMID:26645070.
  5. Gansevoort RT, Meijer E, Chapman AB, Czerwiec FS, Devuyst O, Grantham JJ, Higashihara E, Krasa HB, Ouyang J, Perrone RD, Torres VE; TEMPO 3:4 Investigators. Albuminuria and tolvaptan in autosomal dominant polycystic kidney disease: results of the TEMPO 3:4 Trial. Nephrol Dial Transplant 2015 Dec 17;pii:gfv422; PMID:26681730.
  6. Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkami GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX; Chronic Kidney Disease Prognosis Consortium. Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 2015 Nov 6;PMID:26544982.
  7. Huang N, Foster MC, Lentine KL, Garg AX, Poggio ED, Kasiske BL, Inker LA, Levey AS. Estimated GFR for living kidney donor evaluation. Am J Transplant 2015 Nov 23;doi:10.111/ajt.13540; PMID:26594819.
  8. Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, Contreras G, Greene T, Karger AB, Kusek JW, Lash J, Lewis J, Schelling JR, Navaneethan SD, Sondheimer J, Shafi T, Levey AS. GFR estimation using β-trace protein and β2-microglobulin in CKD. Am J Kidney Dis 2015 Sep 9;pii:S0272-6386(15)01060-4; doi:10.1053/j.ajkd.2015.07.025; PMID:26362696.
  9. Isakova T, Cai X, Lee J, Katz R, Cauley JA, Fried LF, Hoofnagle AN, Satterfield S, Harris TB, Shlipak MG, Sarnak MJ, Ix JH; Health ABC Study. Associations of FGF23 with change in bone mineral density and fracture risk in older individuals. J Bone Miner Res 2015 Nov 21;doi:10.1002/jbmr.2750; PMID:26590361.
  10. Kraut JA, Madias NE. Metabolic acidosis of CKD: an update. Am J Kidney Dis 2015 Oct 15; pii:S0272-6386(15)1211-1;doi:10.1053/j.ajkd.2015.08.028; PMID:26477665.
  11. Laws RL, Brooks DR, Amador JJ, Weiner DE, Kaufman JS, Ramirez-Rubio O, Riefkohl A, Scammell MK, López-Pilarte D, Sánchez JM, Parikh CR, McClean MD. Biomarkers of kidney injury among Nicaraguan sugarcane workers. Am J Kidney Dis 2015 Oct 6;pii:S0272-6386(15)01157-9; doi:10.1053/j.ajkd.2015.08.022; PMID:26454687.
  12. Miskulin DC, Majchrzak K, Tighiouart H, Muther RS, Kapoian T, Johnson DS, Weiner DE. Ergocalciferol supplementation in hemodialysis patients with vitamin D deficiency: a randomized trial. J Am Soc Nephrol 2015 Dec 17;pii:ASN.2015040468; PMID:26677862.
  13. Naimark DM, Grams ME, Matshushita K, Black C, Drion I, Fox CS, Inker LA, Ishani A, Jee SH, Kitamura A, Lea JP, Nally J, Peralta CA, Rothenbacher D, Ryu S, Tonelli M, Yatsuya H, Coresh J, Gansevoort RT, Warnock DG, Woodward M, de Jong PE; CKD Prognosis Consortium. Past decline versus current eGFR and subsequent mortality risk. J Am Soc Nephrol 2015 Dec 11;pii:ASN.2015060688; PMID:26594819.
  14. Okparavero A, Foster MC, Tighiouart H, Gudnason V, Indridason O, Gudmundsdottir H, Eiriksdottir G, Gudmundsson ER, Inker LA, Levey AS. Prevalence and complications of chronic kidney disease in a representative elderly population in Iceland. Nephrol Dial Transplant 2015 Oct 31;pii:gfv370; PMID:26519958.
  15. Ramirez-Rubio O, Amador JJ, Kaufman JS, Weiner DE, Parikh CR, Khan U, McClean MD, Laws RL, López-Pilarte D, Friedman DJ, Kupferman J, Brooks DR. Urine biomarkers of kidney injury among adolescents in Nicaragua, a region affected by an epidemic of chronic kidney disease of unknown etiology. Nephrol Dial Transpl 2015 Aug 25;pii:gfv292; PMID:26311057.
  16. Rebholz CM, Grams ME, Lutsey PL, Hoofnagle AN, Misialek JR, Inker LA, Levey AS, Selvin E, Hsu CY, Kimmel PL, Vasan RS, Eckfeldt JH, Coresh J; Chronic Kidney Disease Biomarkers Consortium. Biomarkers of vitamin D status and risk of ESRD. Am J Kidney Dis 2015 Oct 13;pii:S0272-6386(15)1161-0; doi:10.1053/j.ajkd.2015.08.026; PMID:26475393.
  17. Sarnak MJ, Roberts KE. Pulmonary hypertension in CKD: some answers, yet more questions. J Am Soc Nephrol 2015 Sep 18;pii:ASN.2015070819; PMID:26386071.
  18. Sekula P, Goek ON, Quaye L, Barrios C, Levey AS, Römisch-Margl W, Menni C, Yet I, Gieger C, Inker LA, Adamski J, Gronwald W, Illig T, Dettmer K, Krumsiek J, Oefner PJ, Valdes AM, Meisinger C, Coresh J, Spector TD, Mohney RP, Suhre K, Kastenmüller G, Köttgen A. A metabolome-wide association study of kidney function and disease in the general population. J Am Soc Nephrol 2015 Oct 8;pii:ASN.2014111099; PMID:26449609.
  19. Selamet U, Tighiouart H, Sarnak MJ, Beck G, Levey AS, Block G, Ix JH. Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study. Kidney Int 2015 Sep 30;doi:10.1038/ki.2015.284; PMID:26422502.
  20. Sud M, Tangri N, Pintilie M, Levey AS, Naimark DM. Progression to stage 4 kidney disease and death, acute kidney injury and hospitalization risk: a retrospective cohort study. Nephrol Dial Transplant 2015Nov 20;pii:gfv389; PMID:26590389.
  21. Van Sloten TT, Mitchell GF, Sigurdsson S, van Buchem MA, Jonsoon PV, Garcia ME, Harris TB, Henry RM, Levey AS, Stehouwer CD, Gudnason V, Launer LJ. Associations betwee arterial stiffness, depressive symptoms and cerebral small vessel disease: cross-sectional findings from the AGES-Reykjavik Study. J Psychiatry Neurosci 2015 Oct 20;doi:10.1503/jpn.140334; PMID:26505140.